Find a Trial Find Expert Physicians 
News Trial Stats
Clinical TrialsFacts & Fears Who pays for it, placebos, being a guinea pig, and what taking part really means.Basics ofTheranostics A fundamental way of finding and treating your cancer, all in one.Basics ofRadiation What is radiation, and how can it benefit you? InterpretingYour Scans What CT, MRI and PET can and can’t tell you about cancer.What to Expect as aTheranostic Patient Scans, treatment day, and the precautions once you are home.Basics ofDosimetry How much radiation each organ and tumor actually absorbs.TheranosticDictionary Plain-language meanings for the vocabulary on your paperwork.
News Trial StatsDark mode
Contact XCancer®
Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT03966443
Fluciclovine PET/CT in Multiple Myeloma Patients
Overview
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Sponsor
Odense University Hospital
Contacts
Mona-Elisabeth Revheim, MD, PhD, MHA (CONTACT)
monar@ous-hf.no
+4790659373
ClinicalTrials.gov
NCT03966443Eligibility
Inclusion
- Multiple myeloma patients suitable for ASCT treatment
Exclusion
- Patients with contraindications to ASCT treatment
Share your feedback
Help us improve your experience